Claude B. Sirlin

60.9k total citations · 23 hit papers
485 papers, 41.7k citations indexed

About

Claude B. Sirlin is a scholar working on Epidemiology, Hepatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Claude B. Sirlin has authored 485 papers receiving a total of 41.7k indexed citations (citations by other indexed papers that have themselves been cited), including 337 papers in Epidemiology, 263 papers in Hepatology and 139 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Claude B. Sirlin's work include Liver Disease Diagnosis and Treatment (334 papers), Hepatocellular Carcinoma Treatment and Prognosis (201 papers) and Liver Disease and Transplantation (117 papers). Claude B. Sirlin is often cited by papers focused on Liver Disease Diagnosis and Treatment (334 papers), Hepatocellular Carcinoma Treatment and Prognosis (201 papers) and Liver Disease and Transplantation (117 papers). Claude B. Sirlin collaborates with scholars based in United States, Canada and France. Claude B. Sirlin's co-authors include Rohit Loomba, Lewis R. Roberts, Julie K. Heimbach, Gavin Hamilton, Laura Kulik, Jorge A. Marrero, Andrew X. Zhu, Richard S. Finn, Michaël Abécassis and Michel Pfeffer and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Claude B. Sirlin

471 papers receiving 41.1k citations

Hit Papers

Diagnosis, Staging, and M... 2002 2026 2010 2018 2018 2017 2002 2018 2015 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
    2018 3.1k citations Claude B. Sirlin et al. Hepatology profile →
  2. AASLD guidelines for the treatment of hepatocellular carcinoma
    2017 2.9k citations Claude B. Sirlin et al. Hepatology profile →
  3. Ru-, Rh-, and Pd-Catalyzed C−C Bond Formation Involving C−H Activation and Addition on Unsaturated Substrates:  Reactions and Mechanistic Aspects
    2002 1.8k citations Claude B. Sirlin, Michel Pfeffer et al. profile →
  4. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients
    2018 736 citations Victoria Chernyak, Kathryn J. Fowler et al. Radiology profile →
  5. Nonalcoholic fatty liver disease
    2015 630 citations Claude B. Sirlin et al. profile →
  6. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
    2011 539 citations Scott B. Reeder, Gavin Hamilton et al. Journal of Magnetic Resonance Imaging profile →
  7. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
    2011 537 citations Scott B. Reeder, Gavin Hamilton et al. Journal of Magnetic Resonance Imaging profile →
  8. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
    2019 534 citations Edna Nyangau, Claude B. Sirlin et al. Journal of Clinical Investigation profile →
  9. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
    2016 518 citations Phirum Nguyen, Carolyn Hernandez et al. Gastroenterology profile →
  10. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
    2019 516 citations Claude B. Sirlin et al. profile →
  11. Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis
    2013 433 citations An Tang, Gavin Hamilton et al. Radiology profile →
  12. In vivo characterization of the liver fat 1H MR spectrum
    2010 429 citations Gavin Hamilton, Claude B. Sirlin et al. profile →
  13. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
    2013 422 citations Michael R. Peterson, Michael S. Middleton et al. Hepatology profile →
  14. CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part II. Extracellular Agents, Hepatobiliary Agents, and Ancillary Imaging Features
    2014 397 citations Claude B. Sirlin et al. Radiology profile →
  15. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
    2014 374 citations Rohit Loomba, Jonathan Hooker et al. Hepatology profile →
  16. LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions
    2014 352 citations Donald G. Mitchell, Claude B. Sirlin et al. Hepatology profile →
  17. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
    2017 343 citations An Tang, Victoria Chernyak et al. Abdominal Radiology profile →
  18. Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis
    2017 336 citations Claude B. Sirlin et al. Hepatology profile →
  19. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants
    2018 295 citations Kento Imajo, Jonathan Hooker et al. profile →
  20. Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis
    2017 273 citations Phirum Nguyen, Carolyn Hernandez et al. Hepatology profile →
  21. A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
    2020 240 citations Shirin Bassirian, Seema Singh et al. profile →
  22. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
    2022 162 citations Veeral Ajmera, Egbert Madamba et al. profile →
  23. Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
    2023 102 citations Daniel Q. Huang, Claude B. Sirlin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claude B. Sirlin United States 104 24.6k 20.6k 9.1k 6.1k 4.7k 485 41.7k
Jorge A. Marrero United States 73 16.3k 0.7× 19.7k 1.0× 2.2k 0.2× 4.0k 0.7× 707 0.2× 205 28.6k
Kazuaki Chayama Japan 99 15.7k 0.6× 14.9k 0.7× 1.5k 0.2× 10.7k 1.8× 2.7k 0.6× 1.4k 45.3k
Jacob George Israel 79 16.5k 0.7× 9.1k 0.4× 690 0.1× 3.2k 0.5× 5.1k 1.1× 623 30.4k
W. Ray Kim United States 93 19.5k 0.8× 21.5k 1.0× 767 0.1× 12.0k 2.0× 1.6k 0.3× 391 35.5k
Josep M. Llovet Spain 116 31.2k 1.3× 55.9k 2.7× 5.3k 0.6× 15.5k 2.6× 838 0.2× 357 85.2k
Amit G. Singal United States 78 14.3k 0.6× 16.6k 0.8× 2.0k 0.2× 3.6k 0.6× 814 0.2× 493 29.1k
Jordi Bruix Spain 103 34.0k 1.4× 56.4k 2.7× 5.1k 0.6× 14.7k 2.4× 644 0.1× 380 75.1k
Gregory J. Gores United States 142 20.1k 0.8× 19.0k 0.9× 1.0k 0.1× 23.6k 3.9× 3.0k 0.6× 591 63.2k
Masatoshi Kudo Japan 103 17.6k 0.7× 30.9k 1.5× 3.8k 0.4× 11.0k 1.8× 462 0.1× 1.4k 48.7k
Vincenzo Mazzaferro Italy 74 15.9k 0.6× 26.0k 1.3× 2.4k 0.3× 10.8k 1.8× 482 0.1× 364 39.1k

Countries citing papers authored by Claude B. Sirlin

Since Specialization
Citations

This map shows the geographic impact of Claude B. Sirlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude B. Sirlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude B. Sirlin more than expected).

Fields of papers citing papers by Claude B. Sirlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude B. Sirlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude B. Sirlin. The network helps show where Claude B. Sirlin may publish in the future.

Co-authorship network of co-authors of Claude B. Sirlin

This figure shows the co-authorship network connecting the top 25 collaborators of Claude B. Sirlin. A scholar is included among the top collaborators of Claude B. Sirlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude B. Sirlin. Claude B. Sirlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Sunyoung, Ja Kyung Yoon, Jaeseung Shin, et al.. (2025). US Liver Imaging Reporting and Data System Version 2017: A Systematic Review and Meta-Analysis. Radiology. 314(3). e240450–e240450.
2.
Choi, Sang Hyun, Kathryn J. Fowler, Victoria Chernyak, & Claude B. Sirlin. (2024). LI-RADS: Current Status and Future Directions. Korean Journal of Radiology. 25(12). 1039–1039. 4 indexed citations
3.
Aslam, Anum, Victoria Chernyak, Frank H. Miller, et al.. (2024). CT/MRI LI-RADS 2024 Update: Treatment Response Assessment. Radiology. 313(2). e232408–e232408. 16 indexed citations
4.
Chernyak, Victoria, Kathryn J. Fowler, Richard Kinh Gian, et al.. (2023). LI-RADS: Looking Back, Looking Forward. Radiology. 307(1). 35 indexed citations
5.
Huang, Daniel Q., Harris Siddiqi, Kathryn J. Fowler, et al.. (2023). Cost-Effectiveness Analysis of Hepatocellular Carcinoma Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis Using US Visualization Score C–Triggered Abbreviated MRI. The American Journal of Gastroenterology. 119(7). 1326–1336. 7 indexed citations
6.
Goyal, Nidhi, Patricia Ugalde‐Nicalo, Cynthia Knott, et al.. (2023). Association of Hepatic Steatosis with Adipose and Muscle Mass and Distribution in Children. Metabolic Syndrome and Related Disorders. 21(4). 222–230. 2 indexed citations
7.
Tan, Stéphanie, Muhammad O. Awiwi, Hyun‐Jung Jang, et al.. (2023). Imaging Findings in Cirrhotic Liver: Pearls and Pitfalls for Diagnosis of Focal Benign and Malignant Lesions. Radiographics. 43(9). e230043–e230043. 4 indexed citations
8.
Consul, Nikita, Claude B. Sirlin, Victoria Chernyak, et al.. (2021). Imaging Features at the Periphery: Hemodynamics, Pathophysiology, and Effect on LI-RADS Categorization. Radiographics. 41(6). 1657–1675. 11 indexed citations
9.
Li, Kelvin W., Adina Alazraki, Carine Beysen, et al.. (2021). Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease. Journal of Clinical Investigation. 131(24). 51 indexed citations
10.
Jung, Jinho, Kento Imajo, Egbert Madamba, et al.. (2020). MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis. Gut. 70(10). 1946–1953. 99 indexed citations
11.
Zhang, Yingzhen, Kathryn J. Fowler, Arinc Ozturk, et al.. (2019). Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography. Journal of Magnetic Resonance Imaging. 51(1). 25–42. 65 indexed citations
12.
Kamath, Amita, Elizabeth M. Hecht, Claude B. Sirlin, et al.. (2019). CT/MR LI-RADS 2018: clinical implications and management recommendations. Abdominal Radiology. 44(4). 1306–1322. 26 indexed citations
13.
Ajmera, Veeral, Edward R. Cachay, Christian B. Ramers, et al.. (2019). MRI Assessment of Treatment Response in HIV‐associated NAFLD: A Randomized Trial of a Stearoyl‐Coenzyme‐A‐Desaturase‐1 Inhibitor (ARRIVE Trial). Hepatology. 70(5). 1531–1545. 39 indexed citations
14.
Patel, Janki, Ricki Bettencourt, Jeffrey Cui, et al.. (2016). Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis. Therapeutic Advances in Gastroenterology. 9(5). 692–701. 130 indexed citations
15.
Tang, An, Guy Cloutier, Nikolaus M. Szeverenyi, & Claude B. Sirlin. (2015). Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 1, Principles and Techniques. American Journal of Roentgenology. 205(1). 22–32. 161 indexed citations
16.
Patel, N., Michael R. Peterson, Grace Lin, et al.. (2013). Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls. Gastroenterology Research and Practice. 2013. 1–8. 48 indexed citations
17.
Hines, Catherine D. G., Alex Frydrychowicz, Gavin Hamilton, et al.. (2011). T1 independent, T2* corrected chemical shift based fat–water separation with multi‐peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. Journal of Magnetic Resonance Imaging. 33(4). 873–881. 175 indexed citations
18.
Schwimmer, Jeffrey B., Winston Dunn, Gregory J. Norman, et al.. (2010). SAFETY Study: Alanine Aminotransferase Cutoff Values Are Set Too High for Reliable Detection of Pediatric Chronic Liver Disease. Gastroenterology. 138(4). 1357–1364.e2. 362 indexed citations
19.
Sirlin, Claude B. & Scott B. Reeder. (2010). Magnetic Resonance Imaging Quantification of Liver Iron. Magnetic Resonance Imaging Clinics of North America. 18(3). 359–381. 166 indexed citations
20.
Meng, Xiangjun, Marjorie Jenny, Isabelle Groß, et al.. (2009). A Ruthenium-Containing Organometallic Compound Reduces Tumor Growth through Induction of the Endoplasmic Reticulum Stress Gene CHOP. Cancer Research. 69(13). 5458–5466. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jorge A. Marrero Breakdown of academic impact, for papers by Kazuaki Chayama Breakdown of academic impact, for papers by Jacob George Breakdown of academic impact, for papers by W. Ray Kim Breakdown of academic impact, for papers by Josep M. Llovet Breakdown of academic impact, for papers by Amit G. Singal Breakdown of academic impact, for papers by Jordi Bruix Breakdown of academic impact, for papers by Gregory J. Gores Breakdown of academic impact, for papers by Masatoshi Kudo Breakdown of academic impact, for papers by Vincenzo Mazzaferro
Rankless by CCL
2026